Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Mathai

Showing results (181-190 of 217) with videos related to

Pageof 22
Sort By:
The European Respiratory Journal|November 27, 2020
EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHARMarissa Borgese, David Badesch, Todd Bull, et al.
Circulation. Heart Failure|December 3, 2025
Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary HypertensionYogesh N V Reddy, Robert P Frantz, Anna R Hemnes, et al.
Chest|February 14, 2024
Health-Related Quality of Life Across the Spectrum of Pulmonary HypertensionAparna Balasubramanian, A Brett Larive, Evelyn M Horn, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Single-cell transcriptomics reveal diverging pathobiology and opportunities for precision targeting in scleroderma-associated versus idiopathic pulmonary arterial hypertensionTijana Tuhy, Julie C Coursen, Tammy Graves, et al.
Journal of the American College of Cardiology|October 25, 2024
Clinical Implications of Pretest Probability of HFpEF on Outcomes in Precapillary Pulmonary HypertensionYogesh N V Reddy, Robert P Frantz, Paul M Hassoun, et al.
Journal of the American College of Cardiology|May 7, 2025
Disentangling the Impact of Adiposity From Insulin Resistance in Heart Failure With Preserved Ejection FractionYogesh N V Reddy, Robert P Frantz, Anna R Hemnes, et al.
Circulation. Heart Failure|May 29, 2025
Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary HypertensionYogesh N V Reddy, Robert P Frantz, Paul M Hassoun, et al.
Circulation. Genomic and Precision Medicine|July 21, 2025
Lung Single-Cell Transcriptomics Reveal Diverging Pathobiology and Opportunities for Precision Targeting in Scleroderma-Associated Versus Idiopathic Pulmonary Arterial HypertensionTijana Tuhy, Julie C Coursen, Tammy Graves, et al.
Circulation. Heart Failure|June 26, 2013
Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertensionRyan J Tedford, James O Mudd, Reda E Girgis, et al.
Pulmonary Circulation|October 4, 2021
Right ventricular function as assessed by cardiac magnetic resonance imaging-derived strain parameters compared to high-fidelity micromanometer catheter measurementsTakahiro Sato, Bharath Ambale-Venkatesh, Stefan L Zimmerman, et al.
Pageof 22

Showing results (181-190 of 217) with videos related to

Sort By:
Pageof 22
The European Respiratory Journal|November 27, 2020
EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHARMarissa Borgese, David Badesch, Todd Bull, et al.
Circulation. Heart Failure|December 3, 2025
Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary HypertensionYogesh N V Reddy, Robert P Frantz, Anna R Hemnes, et al.
Chest|February 14, 2024
Health-Related Quality of Life Across the Spectrum of Pulmonary HypertensionAparna Balasubramanian, A Brett Larive, Evelyn M Horn, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Single-cell transcriptomics reveal diverging pathobiology and opportunities for precision targeting in scleroderma-associated versus idiopathic pulmonary arterial hypertensionTijana Tuhy, Julie C Coursen, Tammy Graves, et al.
Journal of the American College of Cardiology|October 25, 2024
Clinical Implications of Pretest Probability of HFpEF on Outcomes in Precapillary Pulmonary HypertensionYogesh N V Reddy, Robert P Frantz, Paul M Hassoun, et al.
Journal of the American College of Cardiology|May 7, 2025
Disentangling the Impact of Adiposity From Insulin Resistance in Heart Failure With Preserved Ejection FractionYogesh N V Reddy, Robert P Frantz, Anna R Hemnes, et al.
Circulation. Heart Failure|May 29, 2025
Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary HypertensionYogesh N V Reddy, Robert P Frantz, Paul M Hassoun, et al.
Circulation. Genomic and Precision Medicine|July 21, 2025
Lung Single-Cell Transcriptomics Reveal Diverging Pathobiology and Opportunities for Precision Targeting in Scleroderma-Associated Versus Idiopathic Pulmonary Arterial HypertensionTijana Tuhy, Julie C Coursen, Tammy Graves, et al.
Circulation. Heart Failure|June 26, 2013
Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertensionRyan J Tedford, James O Mudd, Reda E Girgis, et al.
Pulmonary Circulation|October 4, 2021
Right ventricular function as assessed by cardiac magnetic resonance imaging-derived strain parameters compared to high-fidelity micromanometer catheter measurementsTakahiro Sato, Bharath Ambale-Venkatesh, Stefan L Zimmerman, et al.
Pageof 22